Brought to you by:
The top 10 most popular stories from April
Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels) at vascular surgery meetings, and some of the latest details on the 2021 Vascular Annual Meeting…
Endologix announces launch of Alto abdominal stent graft in Canada
Endologix today announced the first implant of its Alto abdominal stent graft in Canada following recent approval from Health Canada. Alto was also recently approved for commercial sale in Argentina. The company heralds the Alto abdominal stent graft system as…
Plans revealed for pilot study on performance of EVAR for AAA in office-based labs
Details of a planned pilot study investigating the merits of performing endovascular aortic repair (EVAR) on abdominal aortic aneurysms (AAAs) in office-based labs (OBLs) and other free-standing ambulatory facilities emerged during the recent Critical Issues America annual meeting (April 16–17)…
Registry data show EVAR is safe, durable and effective out to five years
Endovascular aortic repair (EVAR) is safe, durable and effective, the five-year interim results of the Global Registry for Endovascular Aortic Treatment (the GREAT registry) show. In this analysis of more than 3,000 abdominal aortic aneurysm (AAA) patients treated with an…
Patients with AAAs who had COVID-19 may need ‘more frequent surveillance’ until better understanding of link emerges
Patients who have known abdominal aortic aneurysms (AAAs), who may have had a COVID-19 infection, might need to have more frequent or a different surveillance regimen until a better understanding of the relationship between the virus and potential symptomatic progression…
‘Radiation will be a thing of the past’
Discussion during the opening day of the Charing Cross (CX) 2021 Digital Edition emphasized the potential of Philips’ Fiber Optic RealShape (FORS) technology to reduce radiation and ease technical success, with moderator Gustavo Oderich, MD, professor and chief of vascular…
US surgeons begin commercial use of Gore Excluder conformable AAA endoprosthesis with Active Control system
W. L. Gore & Associates (Gore) today announced the first use of the Food and Drug Administration (FDA)-approved Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprothesis with Active Control system in cases outside of clinical trials. Cases were successfully performed…
First patient treated in the BeGraft FEVAR study aimed at providing evidence for on-label use
The first patient has been included in the BeGraft fenestrated endovascular aneurysm repair (FEVAR) study investigating the Bentley BeGraft peripheral balloon expandable covered stent in complex aortic aneurysms. The patient was referred for FEVAR with a 6cm juxtarenal abdominal aortic…
EVAR improves one-year survival in octogenarians with AAAs, study finds
Endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) in those 80-plus decreases one-year mortality rates compared to non-operative management, researchers at the University of Texas (UT) Southwestern Medical Center in Dallas found. Working from a cohort of 11,829 patients…
Pioneering Duke vascular surgeon Richard McCann dies
Richard McCann, MD, a vascular surgeon who reinvented his skills after the endovascular revolution in the 1990s and implanted the first endograft for an abdominal aortic aneurysm (AAA) at Duke University in Durham, North Carolina, has died. Born in Portland,…